申请人:Eli Lilly and Company
公开号:US20150368240A1
公开(公告)日:2015-12-24
The present invention provides compounds of the formula (I) or a pharmaceutically acceptable salt thereof. Compounds of the invention are autotaxin inhibitors useful in the treatment of pain associated with osteoarthritis.
本发明提供式(I)的化合物或其药学上可接受的盐。本发明的化合物是自体脂肪酶抑制剂,适用于治疗与骨关节炎相关的疼痛。